Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
Summary
Company advances focused strategy, strengthens balance sheet and positions business for long-term growth
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.